There have been no open-market insider trades at Blueprint Medicines Corp in the last 12 months.
Quarter by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
There have been no open-market insider trades at Blueprint Medicines Corp in the last 12 months.
Quarter by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Jul 8, 2025 | Rossi Christina | COO | Sell | 1,172 | $128.25 | $150K | SEC |
| Jul 8, 2025 | Carter Percy H. | Executive Officer | Sell | 1,051 | $128.25 | $135K | SEC |
| Jun 5, 2025 | Carter Percy H. | Executive Officer | Sell | 241 | $127.88 | $31K | SEC |
| Jun 5, 2025 | Carter Percy H. | Executive Officer | Sell | 2,418 | $127.88 | $309K | SEC |
| May 29, 2025 | Albers Jeffrey W. | Director | Sell | 4,350 | $101.02 | $439K | SEC |
| May 29, 2025 | Albers Jeffrey W. | Director | Sell | 650 | $101.93 | $66K | SEC |
| May 21, 2025 | Rossi Christina | COO | Sell | 804 | $100.14 | $81K | SEC |
| May 21, 2025 | Rossi Christina | COO | Sell | 57 | $101.72 | $6K | SEC |
| May 21, 2025 | Rossi Christina | COO | Sell | 1,413 | $100.67 | $142K | SEC |
| May 7, 2025 | Rossi Christina | COO | Sell | 1,343 | $101.77 | $137K | SEC |
| May 7, 2025 | Rossi Christina | COO | Sell | 144 | $103.56 | $15K | SEC |
| May 7, 2025 | Rossi Christina | COO | Sell | 180 | $102.82 | $19K | SEC |
| May 7, 2025 | Rossi Christina | COO | Sell | 607 | $100.97 | $61K | SEC |
| May 7, 2025 | Hurley Ariel | Officer | Sell | 1,252 | $102.51 | $128K | SEC |
| May 7, 2025 | Hurley Ariel | Officer | Sell | 100 | $104.78 | $10K | SEC |
There were no open-market insider trades in BPMC in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
No congressional trades in BPMC were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).